Rose Merc Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Rose Merc. Ltd is ₹ 42.1 as of 23 Oct 15:30 . The P/E Ratio of Rose Merc. Ltd changed from 151.8 on March 2024 to 7.3 on March 2026 . This represents a CAGR of -63.63% over 3 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 0 on March 2023 to 0 on March 2026 . This represents a CAGR of 0.0% over 4 years The Market Cap of Rose Merc. Ltd changed from ₹ 9.63 crore on March 2023 to ₹ 41.76 crore on March 2026 . This represents a CAGR of 44.31% over 4 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2023 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 4 years The revenue of Rose Merc. Ltd for the Jun '26 is ₹ 27.96 crore as compare to the Mar '26 revenue of ₹ 27.69 crore. This represent the growth of 0.98% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Rose Merc. Ltd for the Jun '26 is ₹ 5.72 crore as compare to the Mar '26 ebitda of ₹ 5.27 crore. This represent the growth of 8.54% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Rose Merc. Ltd changed from ₹ -0.41 crore to ₹ 5.45 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Rose Merc. Ltd changed from 23.32 % on March 2024 to 59.5 % on March 2026 . This represents a CAGR of 36.65% over 3 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Rose Merc. Ltd

Rose Merc Limited is a dynamic group with a profound understanding of the Indian consumer across various sectors.
With years of experience, a robust growth generation capability, and a team of highly qualified and experienced board members, the Company has constructed a diversified business portfolio spanning a wide range of B2C sectors. Rose Merc Limited was established in January, 1985.
The Company mainly involved in trading of General Merchandise and allied items along with finance and investment based activities.
Their diverse portfolio includes event management services, Spiritual Radio Broadcast, Sports Management, Customer B2C Product and Financial Consulting Services, all operating under one roof. During the year 2024, Company has amended the Memorandum of Association and altered its Object Clause to carry out various activities including the following: 1.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Rose Merc. Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Rose Merc. Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Rose Merc. Ltd is 33 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Rose Merc. Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Rose Merc. Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Rose Merc. Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Rose Merc. Ltd stock price is INR ₹42.1. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Rose Merc. Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Rose Merc. Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.